Michael v Blommestein

Non-Executive Director / Apiam Animal Health

Mr Blommestein was a Vice President and Country Manager of Australia and New Zealand for Zoetis and managed the spin-off of Zoetis from Pfizer Australia. He is an experienced director in the animal health sector. Michael also acts as a consultant to IRP Health.

Lists and Charts

Share Transactions

Person Activity

NEW ROLE: Non-Executive Director, Apiam Animal Health

03 Nov 2020

Related Information

Positions - Current

Position	Company	Year	Company's current rank	WA staff
Non-Executive Director	Apiam Animal Health

Remuneration

Company	Total	Base	Bonuses	Shares	Options	Super	Other	Year
Apiam Animal Health	28,891	26,146				2,745	0	2023

Directors Interest

Company	Date	Transaction type	Number of shares	Price per share	Transaction value	Nature of change
Apiam Animal Health	2022-10-21	Bought	593	$0.75	$445	Dividend Reinvestment Plan (DRP)
Apiam Animal Health	2022-04-20	Bought	1,581	$0.83	$1,316	Dividend Reinvestment Plan (DRP)
Apiam Animal Health	2021-10-22	Bought	1,327	$0.98	$1,300	Dividend Reinvestment Plan (DRP)
Apiam Animal Health	2021-04-23	Bought	1,582	$0.81	$1,281	Dividend Reinvestment Plan (DRP)
Apiam Animal Health	2020-10-23	Bought	2,041	$0.62	$1,256	Dividend Reinvestment Plan (DRP)

Explore Full List